biosimulation


Also found in: Medical.

bi·o·sim·u·la·tion

 (bī′ō-sĭm′yə-lā′shən)
n.
The simulating of a biological process, such as glucose metabolism, in a cell, organ, or organism, by means of a computer program, used especially in pharmaceutical research.
References in periodicals archive ?
Biosimulation Market - https://www.grandviewresearch.com/industry-analysis/biosimulation-industry
Colding-Jorgensen, "Biosimulation of peptides and proteins," in Pharmaceutical Formulation Development of Peptides and Proteins, L.
FDA in 2015, more than 90 percent leveraged biosimulation to inform that drug label.
1 December 2015 - US-based biosimulation technology-enabled drug development company Certara has acquired XenologiQ, a UK-based quantitative systems pharmacology consultancy, the company said.
[ClickPress, Thu Aug 20 2015] Biosimulation Market by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), Application (Drug Discovery & Development, Preclinical, Clinical Trial) & by End Users - Global Forecast to 2020
is employed by BioSimulation Consulting Inc., Newark, DE.
Gene Network Sciences is a leader in biosimulation with its ability to derive molecular mechanisms of drugs and diseases directly from molecular profiling and clinical data.
Biosimulation involves the use of computational models for providing dynamic and quantitative description of relevant biological, pathological, and pharmacokinetic processes in drug discovery and development.
Pfizer, Groton, Conn., recently won a Best Practices in drug discovery and development award from BioIT World for the best implementation in biosimulation based on presented findings from a joint research program with Entelos in which they demonstrated a pronounced time-savings in both target validation and candidate selection.
And it is easy to imagine the convergence of biosimulation and telesurgery in the near future.